A detailed history of Turtle Creek Wealth Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Turtle Creek Wealth Advisors, LLC holds 4,735 shares of ABT stock, worth $563,228. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,735
Previous 4,506 5.08%
Holding current value
$563,228
Previous $468 Million 15.3%
% of portfolio
0.11%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$100.07 - $118.13 $22,916 - $27,051
229 Added 5.08%
4,735 $540 Million
Q2 2024

Jul 31, 2024

BUY
$100.73 - $112.44 $50,767 - $56,669
504 Added 12.59%
4,506 $468 Million
Q1 2024

Apr 30, 2024

BUY
$109.52 - $120.96 $172,165 - $190,149
1,572 Added 64.69%
4,002 $455 Million
Q4 2023

Jan 26, 2024

BUY
$90.19 - $110.4 $219,161 - $268,272
2,430 New
2,430 $267 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Turtle Creek Wealth Advisors, LLC Portfolio

Follow Turtle Creek Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Turtle Creek Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Turtle Creek Wealth Advisors, LLC with notifications on news.